Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOW LONG
NCT07328984Phase 4Not yet recruiting
- Sponsor
- McGill University Health Centre
- Start
- Jan 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Pneumocystis jirovecii pneumonia (PJP) (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Hierarchical composite clinical outcome at Day 60. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT07328984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07328984.